CME Group (NASDAQ:CME) Stock Keeps Buy Rating at TD Cowen

CME Group (NASDAQ:CME)‘s stock had its “buy” rating restated by equities research analysts at TD Cowen in a research report issued on Monday, Benzinga reports. They currently have a $292.00 price objective on the financial services provider’s stock. TD Cowen’s target price would indicate a potential upside of 10.27% from the company’s current price.

Other analysts have also recently issued reports about the company. Barclays reduced their price target on CME Group from $316.00 to $270.00 and set an “equal weight” rating on the stock in a report on Thursday, July 9th. Morgan Stanley boosted their price target on CME Group from $324.00 to $330.00 and gave the stock an “overweight” rating in a report on Thursday, July 23rd. UBS Group cut their target price on CME Group from $310.00 to $260.00 and set a “buy” rating on the stock in a report on Monday, July 6th. JPMorgan Chase & Co. lifted their target price on CME Group from $249.00 to $250.00 and gave the stock an “underweight” rating in a report on Thursday, July 23rd. Finally, Rothschild & Co Redburn raised CME Group from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $316.00 to $323.00 in a report on Thursday, June 11th. Eight equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, CME Group currently has an average rating of “Hold” and a consensus target price of $289.07.

CME Group Trading Up 0.1%

Shares of NASDAQ:CME traded up $0.31 during midday trading on Monday, hitting $264.79. 417,516 shares of the stock were exchanged, compared to its average volume of 2,555,325. The stock has a market capitalization of $95.21 billion, a price-to-earnings ratio of 22.44, a P/E/G ratio of 3.13 and a beta of 0.24. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The business’s 50-day moving average price is $269.53 and its 200 day moving average price is $273.89. CME Group has a 12 month low of $218.31 and a 12 month high of $329.16.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, topping the consensus estimate of $2.91 by $0.08. The company had revenue of $1.71 billion for the quarter, compared to analysts’ expectations of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The business’s quarterly revenue was up .8% compared to the same quarter last year. During the same period in the previous year, the business posted $2.96 earnings per share. Analysts predict that CME Group will post 12.27 earnings per share for the current year.

Insiders Place Their Bets

In related news, CEO Terrence Duffy sold 15,000 shares of CME Group stock in a transaction on Thursday, September 10th. The shares were sold at an average price of $274.44, for a total transaction of $4,116,600.00. Following the completion of the transaction, the chief executive officer owned 40,630 shares of the company’s stock, valued at $11,150,497.20. This trade represents a 26.96% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Elizabeth Cook sold 500 shares of CME Group stock in a transaction on Monday, September 14th. The stock was sold at an average price of $280.11, for a total transaction of $140,055.00. Following the transaction, the director directly owned 17,916 shares of the company’s stock, valued at $5,018,450.76. This represents a 2.72% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.30% of the stock is owned by company insiders.

Institutional Trading of CME Group

Large investors have recently modified their holdings of the stock. Whipplewood Advisors LLC grew its position in shares of CME Group by 2,075.0% during the 1st quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock worth $26,000 after buying an additional 83 shares during the period. Hilton Head Capital Partners LLC acquired a new stake in shares of CME Group during the 4th quarter worth approximately $28,000. Main Street Group LTD acquired a new stake in shares of CME Group during the 1st quarter worth approximately $32,000. Bayban acquired a new stake in shares of CME Group during the 4th quarter worth approximately $31,000. Finally, Mowery & Schoenfeld Wealth Management LLC acquired a new stake in shares of CME Group during the 2nd quarter worth approximately $28,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

About CME Group

CME Group Inc operates global derivatives marketplaces that provide trading, clearing and settlement services for a broad range of financial and commodity products. Its exchange platforms enable participants to manage risk, discover prices and gain exposure to asset classes including interest rates, equity indexes, foreign exchange, energy, metals, agricultural commodities and digital assets.

The company’s principal marketplaces include CME, CBOT, NYMEX and COMEX. Products are offered through futures and options contracts, with electronic trading available through CME Globex as well as exchange-based and privately negotiated transactions.